公开(公告)号：US20210355151A1

公开(公告)日：2021-11-18

申请号：US17257255

申请日：2019-03-08

Applicant: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY

Inventor： Hee Jae Shin ,  Byeoung Kyu Choi ,  Hwa Sun Lee ,  Hyi Seung Lee ,  Yeon Ju Lee ,  Jong Seok Lee ,  Ji Hoon Lee ,  Chan Hong Park

IPC: C07H15/04 ,  C07H1/00

Abstract: Disclosed are a novel rhamnolipid compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof in the present disclosure. The novel rhamnolipid compound, the optical isomer thereof, or the pharmaceutically acceptable salt thereof selectively exhibits cytotoxicity to human cancer cell lines, thereby inhibiting the growth of cancer cells, and thus has particularly excellent preventive or therapeutic effects against the above-mentioned types of cancers.

公开(公告)号：US11286273B2

公开(公告)日：2022-03-29

申请号：US17257255

申请日：2019-03-08

Applicant: KOREA INSTITUTE OF OCEAN SCIENCE & TECHNOLOGY

Inventor： Hee Jae Shin ,  Byeoung Kyu Choi ,  Hwa Sun Lee ,  Hyi Seung Lee ,  Yeon Ju Lee ,  Jong Seok Lee ,  Ji Hoon Lee ,  Chan Hong Park

IPC: C07H15/04 ,  C07H1/00

Abstract: Disclosed are a novel rhamnolipid compound, an optical isomer thereof, or a pharmaceutically acceptable salt thereof in the present disclosure. The novel rhamnolipid compound, the optical isomer thereof, or the pharmaceutically acceptable salt thereof selectively exhibits cytotoxicity to human cancer cell lines, thereby inhibiting the growth of cancer cells, and thus has particularly excellent preventive or therapeutic effects against the above-mentioned types of cancers.